Company / Depreciation & Amortization
Phathom Pharmaceuticals, Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$633.0K
FY2025
5-year range
$521.0K / $633.0K
FY2021-FY2025
Trend
+10.1%
vs FY2024
Sector context
#127 of 163
Health Care
What the data says
Phathom Pharmaceuticals, Inc.'s depreciation & amortization of $633,000 is lower than 78% of companies in the Health Care sector (FY2025). Increased from $575,000 to $633,000 over the past 2 years.
Based on SEC 10-K filings.
$633,000 in FY2025 with a 5-year CAGR of +14.4%.
Increased from $575,000 to $633,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- +14.4%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 163This company $633.0K Sector average $219.4M
▼
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.4%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 10.1% year-over-year.
- Ranks #127 out of 163 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $633.0K | +10.1% |
| FY2024 | $575.0K | +0.0% |
| FY2023 | $575.0K | -7.3% |
| FY2022 | $620.0K | +19.0% |
| FY2021 | $521.0K | +61.3% |
| FY2020 | $323.0K | +3937.5% |
| FY2019 | $8.0K | - |
| FY2018 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026